Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature

Sandro Loche, Paola Cambiaso, Stefano Setzu, Daniela Carta, Romana Marini, Patrizia Borrelli, Marco Cappa

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

We report the effect of growth hormone (GH) treatment for 4 to 10 years in 15 prepubertal non-GH-deficient short children (10 boys, 5 girls, aged 7.4 to 13.2 years). In 7 patients, GH was administered at a dosage of 0.5 U/kg per week (group 1: 4 boys, 3 girls) and in 8 patients (group 2: 6 boys, 2 girls) at a dosage of 1.0 U/kg per week. After the first year, mean linear growth velocity had significantly increased in both groups. The increase in growth velocity was sustained during the first 4 years and then declined to pretreatment values in the majority of subjects. Treatment with GH did not induce an earlier onset of puberty, but there was a tendency toward faster skeletal maturation. The mean final height standard deviation score (SDS) was similar in the two groups and was significantly higher than the height SDS for chronologic age before treatment, but it did not differ from mean pretreatment predicted adult height SDS nor from mean target height SDS in both groups. Final height was significantly correlated with target height in both groups. These preliminary observations indicate that GH treatment does not generally increase final height over target height in short non-GH-deficient children. (J PEDIATR 1994;125:196-200).

Original languageEnglish
Pages (from-to)196-200
Number of pages5
JournalJournal of Pediatrics
Volume125
Issue number2
DOIs
Publication statusPublished - 1994

Fingerprint

Growth Hormone
Hormones
Therapeutics
Puberty
Growth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. / Loche, Sandro; Cambiaso, Paola; Setzu, Stefano; Carta, Daniela; Marini, Romana; Borrelli, Patrizia; Cappa, Marco.

In: Journal of Pediatrics, Vol. 125, No. 2, 1994, p. 196-200.

Research output: Contribution to journalArticle

Loche, Sandro ; Cambiaso, Paola ; Setzu, Stefano ; Carta, Daniela ; Marini, Romana ; Borrelli, Patrizia ; Cappa, Marco. / Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. In: Journal of Pediatrics. 1994 ; Vol. 125, No. 2. pp. 196-200.
@article{8dc62bc3438147e998e025fde3974240,
title = "Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature",
abstract = "We report the effect of growth hormone (GH) treatment for 4 to 10 years in 15 prepubertal non-GH-deficient short children (10 boys, 5 girls, aged 7.4 to 13.2 years). In 7 patients, GH was administered at a dosage of 0.5 U/kg per week (group 1: 4 boys, 3 girls) and in 8 patients (group 2: 6 boys, 2 girls) at a dosage of 1.0 U/kg per week. After the first year, mean linear growth velocity had significantly increased in both groups. The increase in growth velocity was sustained during the first 4 years and then declined to pretreatment values in the majority of subjects. Treatment with GH did not induce an earlier onset of puberty, but there was a tendency toward faster skeletal maturation. The mean final height standard deviation score (SDS) was similar in the two groups and was significantly higher than the height SDS for chronologic age before treatment, but it did not differ from mean pretreatment predicted adult height SDS nor from mean target height SDS in both groups. Final height was significantly correlated with target height in both groups. These preliminary observations indicate that GH treatment does not generally increase final height over target height in short non-GH-deficient children. (J PEDIATR 1994;125:196-200).",
author = "Sandro Loche and Paola Cambiaso and Stefano Setzu and Daniela Carta and Romana Marini and Patrizia Borrelli and Marco Cappa",
year = "1994",
doi = "10.1016/S0022-3476(94)70192-X",
language = "English",
volume = "125",
pages = "196--200",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature

AU - Loche, Sandro

AU - Cambiaso, Paola

AU - Setzu, Stefano

AU - Carta, Daniela

AU - Marini, Romana

AU - Borrelli, Patrizia

AU - Cappa, Marco

PY - 1994

Y1 - 1994

N2 - We report the effect of growth hormone (GH) treatment for 4 to 10 years in 15 prepubertal non-GH-deficient short children (10 boys, 5 girls, aged 7.4 to 13.2 years). In 7 patients, GH was administered at a dosage of 0.5 U/kg per week (group 1: 4 boys, 3 girls) and in 8 patients (group 2: 6 boys, 2 girls) at a dosage of 1.0 U/kg per week. After the first year, mean linear growth velocity had significantly increased in both groups. The increase in growth velocity was sustained during the first 4 years and then declined to pretreatment values in the majority of subjects. Treatment with GH did not induce an earlier onset of puberty, but there was a tendency toward faster skeletal maturation. The mean final height standard deviation score (SDS) was similar in the two groups and was significantly higher than the height SDS for chronologic age before treatment, but it did not differ from mean pretreatment predicted adult height SDS nor from mean target height SDS in both groups. Final height was significantly correlated with target height in both groups. These preliminary observations indicate that GH treatment does not generally increase final height over target height in short non-GH-deficient children. (J PEDIATR 1994;125:196-200).

AB - We report the effect of growth hormone (GH) treatment for 4 to 10 years in 15 prepubertal non-GH-deficient short children (10 boys, 5 girls, aged 7.4 to 13.2 years). In 7 patients, GH was administered at a dosage of 0.5 U/kg per week (group 1: 4 boys, 3 girls) and in 8 patients (group 2: 6 boys, 2 girls) at a dosage of 1.0 U/kg per week. After the first year, mean linear growth velocity had significantly increased in both groups. The increase in growth velocity was sustained during the first 4 years and then declined to pretreatment values in the majority of subjects. Treatment with GH did not induce an earlier onset of puberty, but there was a tendency toward faster skeletal maturation. The mean final height standard deviation score (SDS) was similar in the two groups and was significantly higher than the height SDS for chronologic age before treatment, but it did not differ from mean pretreatment predicted adult height SDS nor from mean target height SDS in both groups. Final height was significantly correlated with target height in both groups. These preliminary observations indicate that GH treatment does not generally increase final height over target height in short non-GH-deficient children. (J PEDIATR 1994;125:196-200).

UR - http://www.scopus.com/inward/record.url?scp=0027978882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027978882&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(94)70192-X

DO - 10.1016/S0022-3476(94)70192-X

M3 - Article

C2 - 8040761

AN - SCOPUS:0027978882

VL - 125

SP - 196

EP - 200

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -